| Mr Ian Christopher Paul, PT | |
|
147 Mescalero Trl, Ruidoso, NM 88345-6090 | |
| (575) 257-5820 | |
| Not Available |
| Full Name | Mr Ian Christopher Paul |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 147 Mescalero Trl, Ruidoso, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093046393 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 3453 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ian Christopher Paul, PT Po Box 7100, Ruidoso, NM 88355-7100 Ph: (575) 257-5820 | Mr Ian Christopher Paul, PT 147 Mescalero Trl, Ruidoso, NM 88345-6090 Ph: (575) 257-5820 |
News Archive
A recent study published in the journal JAMA Network Open reveals that the excess death toll observed during the initial period of coronavirus disease 2019 (COVID-19) pandemic in New York City is comparable to that observed during the peak of the H1N1 influenza pandemic in 1918.
Zalicus Inc., and Epirus Biopharmaceuticals, Inc., a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced today that they have entered into a definitive agreement under which Epirus will merge with a wholly-owned subsidiary of Zalicus in an all-stock transaction.
A hospital that is using RapidArc radiotherapy to treat cancers of the head & neck and cervix is announcing it will be expanding its use for treatment of other cancers. Yashoda Cancer Institute in Hyderabad has found it can deliver image-guided, intensity modulated radiotherapy (IMRT) faster and more precisely using the RapidArc technology from Varian Medical Systems.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
› Verified 1 days ago
Mrs. Roberta Renee Regalado, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 628 Sudderth Dr, Ruidoso, NM 88345 Phone: 575-257-5820 Fax: 575-257-9560 | |
Mr. Ryan David Biricocchi, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 Mescalero Trl, Ruidoso, NM 88345 Phone: 505-257-5820 Fax: 505-257-9560 | |
Dana M Wade, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1129 Mechem Dr Ste C, Ruidoso, NM 88345 Phone: 575-808-8721 Fax: 575-808-8723 | |
Lydia C. Radosevich, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 439 Mechem Dr, Ruidoso, NM 88345 Phone: 505-257-1800 Fax: 505-257-2319 | |
Marla Loree Wall, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 Mescalero Trl, Ruidoso, NM 88345 Phone: 575-257-5820 | |
Ruidoso Physical Therapy Clinic, Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 439 Mechem Dr, Ruidoso, NM 88345 Phone: 575-257-1800 Fax: 575-257-2319 |